TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis

NCT01657513 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: subjects will receive either infliximab, adalimumab or etanercept

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]
[object Object]